Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor‐cleaving protease
- 1 April 2001
- journal article
- case report
- Published by Wiley in British Journal of Haematology
- Vol. 113 (1) , 100-102
- https://doi.org/10.1046/j.1365-2141.2001.02704.x
Abstract
Complete deficiency of von Willebrand factor‐cleaving protease (VWF‐cp) has recently been identified as a pathogenetically important factor for thrombotic thrombocytopenic purpura (TTP). Microangiopathic haemolytic anaemia (MAHA) with thrombocytopenia in patients with metastasizing neoplasms is clinically similar to TTP, however, the pathogenesis of the condition is unclear. Partial deficiency of VWF‐cp in metastasizing malignancy has recently been reported in patients without MAHA. Our study shows normal or subnormal VWF‐cp activity in four patients with metastasizing neoplasia‐associated MAHA but, in contrast to classical TTP, no complete deficiency of VWF‐cp despite the full clinical picture of MAHA.Keywords
This publication has 12 references indexed in Scilit:
- Thrombotic Microangiopathy Manifesting as Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome in the Cancer PatientSeminars in Thrombosis and Hemostasis, 1999
- Assay of von Willebrand Factor (vWF)-cleaving Protease Based on Decreased Collagen Binding Affinity of Degraded vWFThrombosis and Haemostasis, 1999
- Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1998
- von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic SyndromeNew England Journal of Medicine, 1998
- Thrombotic Thrombocytopenic Purpura: Understanding a Disease No Longer RareThe Lancet Healthy Longevity, 1998
- Acquired Deficiency of von Willebrand Factor-Cleaving Protease in a Patient With Thrombotic Thrombocytopenic PurpuraBlood, 1998
- Deficient Activity of von Willebrand Factor–Cleaving Protease in Chronic Relapsing Thrombotic Thrombocytopenic PurpuraBlood, 1997
- A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndromeEuropean Journal Of Cancer, 1993
- Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpuraBritish Journal of Haematology, 1990
- Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.Journal of Clinical Oncology, 1985